Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Angela Iervolino"'
Autor:
Donatella Del Bufalo, Daniela Trisciuoglio, Marco Scarsella, Giulia D'Amati, Antonio Candiloro, Angela Iervolino, Carlo Leonetti, Gabriella Zupi
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 5, Pp 513-522 (2004)
The aim of this study was to assess whether lonidamine (LND) interferes with some steps in angiogenesis progression. We report here, for the first time, that LND inhibited angiogenic-related endothelial cell functions in a dose-dependent manner (1-50
Externí odkaz:
https://doaj.org/article/fa8f9e2ff973440088bc46cd77bec953
Autor:
Angela Iervolino, Rodolfo Iuliano, Francesco Trapasso, Giuseppe Viglietto, Rosa Marina Melillo, Francesca Carlomagno, Massimo Santoro, Alfredo Fusco
Publikováno v:
Cancer research. 78(24)
Autor:
Beatrice D'Orsi, Gaia Gestri, Marianna Vitiello, Massimiliano Andreazzoli, Manuela Barilari, Angela Iervolino, Luciana Dente, Elena Landi, Stephen W. Wilson
Publikováno v:
Biochimie. 94(9):2054-2057
We report the identification of a novel partner of Kidins220/ARMS (Kinase D-interacting substrate of 220 kDa/Ankyrin Repeat-rich Membrane Spanning) an adaptor of neurotrophin receptors playing crucial roles during neurogenesis. Screening a phage disp
Publikováno v:
Molecular Biology of the Cell. 16:4153-4162
We have previously demonstrated that bcl-2 overexpression in tumor cells exposed to hypoxia increases the expression of vascular endothelial growth factor (VEGF) gene through the hypoxia-inducible factor-1 (HIF-1). In this article, we demonstrate tha
Autor:
Daniela Trisciuoglio, Marco Scarsella, Angela Iervolino, Giulia d'Amati, Donatella Del Bufalo, Gabriella Zupi, Carlo Leonetti, Antonio Candiloro
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 6, Iss 5, Pp 513-522 (2004)
The aim of this study was to assess whether lonidamine (LND) interferes with some steps in angiogenesis progression. We report here, for the first time, that LND inhibited angiogenic-related endothelial cell functions in a dose-dependent manner (1-50
Autor:
Antonio Candiloro, Uwe Zangemeister-Wittke, Gabriella Fibbi, Daniela Trisciuoglio, Angela Iervolino, Donatella Del Bufalo, Maurizio Fanciulli, Gabriella Zupi
Publikováno v:
Journal of Biological Chemistry. 279:6737-6745
We have previously demonstrated that Bcl-2 overexpression in human breast carcinoma and melanoma cells synergizes with hypoxia to increase angiogenesis through up-regulation of vascular endothelial growth factor. In this work we demonstrated, for the
Autor:
Kenneth Campbell, Rossana Trotta, Danilo Perrotti, Vincenzo Cesi, Carlo Gambacorti-Passerini, Giorgia Santilli, Angela Iervolino, Bruno Calabretta, Clara Guerzoni, Fabrizio Condorelli, Michael A. Caligiuri
Publikováno v:
Nature Genetics. 30:48-58
The arrest of differentiation is a feature of both chronic myelogenous leukemia cells in myeloid blast crisis and myeloid precursors that ectopically express the p210BCR-ABL oncoprotein; however, its underlying mechanisms remain poorly understood. He
Autor:
Emanuela Grassilli, Silvia Lombardini, Maria Cirinnà, Bruno Calabretta, Pier Paolo Claudio, Angela Iervolino, Vincenzo Cesi, Danilo Perrotti, Silvia Bonatti
Publikováno v:
Molecular and Cellular Biology. 20:6159-6169
The DNA binding activity of FUS (also known as TLS), a nuclear pro-oncogene involved in multiple translocations, is regulated by BCR-ABL in a protein kinase CbetaII (PKCbetaII)-dependent manner. We show here that in normal myeloid progenitor cells FU
Autor:
Salvatore Salzano, Matilde Valeria Ursini, Francesca Salvemini, Angela Iervolino, Stefania Filosa, Annamaria Franzè
Publikováno v:
The Journal of biological chemistry
274 (1999): 2750–2757.
info:cnr-pdr/source/autori:Salvemini F, Franzé A, Iervolino A, Filosa S, Salzano S, Ursini MV./titolo:Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression./doi:/rivista:The Journal of biological chemistry (Print)/anno:1999/pagina_da:2750/pagina_a:2757/intervallo_pagine:2750–2757/volume:274
274 (1999): 2750–2757. doi:10.1074/jbc.274.5.2750
info:cnr-pdr/source/autori:SALVEMINI F, FRANZE A, IERVOLINO A, FILOSA S, SALZANO S, URSINI MV/titolo:Enhanced glutathione levels oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression/doi:10.1074%2Fjbc.274.5.2750/rivista:The Journal of biological chemistry (Print)/anno:1999/pagina_da:2750/pagina_a:2757/intervallo_pagine:2750–2757/volume:274
274 (1999): 2750–2757.
info:cnr-pdr/source/autori:Salvemini F, Franzé A, Iervolino A, Filosa S, Salzano S, Ursini MV./titolo:Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression./doi:/rivista:The Journal of biological chemistry (Print)/anno:1999/pagina_da:2750/pagina_a:2757/intervallo_pagine:2750–2757/volume:274
274 (1999): 2750–2757. doi:10.1074/jbc.274.5.2750
info:cnr-pdr/source/autori:SALVEMINI F, FRANZE A, IERVOLINO A, FILOSA S, SALZANO S, URSINI MV/titolo:Enhanced glutathione levels oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression/doi:10.1074%2Fjbc.274.5.2750/rivista:The Journal of biological chemistry (Print)/anno:1999/pagina_da:2750/pagina_a:2757/intervallo_pagine:2750–2757/volume:274
Glucose-6-phosphate dehydrogenase (G6PD) is the key enzyme of the pentose phosphate pathway that is responsible for the generation of NADPH, which is required in many detoxifying reactions. We have recently demonstrated that G6PD expression is induce
Autor:
Alessandra Cianflone, Carlo M. Croce, Hansjuerg Alder, Rodolfo Iuliano, Albert de la Chapelle, Eleonora Borbone, Francesco Trapasso, Huiling He, Carla Giordano, George A. Calin, Rebecca Nagy, Dario Palmieri, Pierlorenzo Pallante, Alfredo Fusco, Angela Iervolino
Publikováno v:
Endocrine-related cancer 17 (2010): 1001–1006. doi:10.1677/ERC-10-0143
info:cnr-pdr/source/autori:Iuliano, Rodolfo; Palmieri, Dario; He, Huiling; Iervolino, Angela; Borbone, Eleonora; Pallante, Pierlorenzo; Cianflone, Alessandra; Nagy, Rebecca; Alder, Hansjuerg; Calin, George A.; Trapasso, Francesco; Giordano, Carla; Croce, Carlo M.; de la Chapelle, Albert; Fusco, Alfredo/titolo:Role of PTPRJ genotype in papillary thyroid carcinoma risk/doi:10.1677%2FERC-10-0143/rivista:Endocrine-related cancer/anno:2010/pagina_da:1001/pagina_a:1006/intervallo_pagine:1001–1006/volume:17
info:cnr-pdr/source/autori:Iuliano, Rodolfo; Palmieri, Dario; He, Huiling; Iervolino, Angela; Borbone, Eleonora; Pallante, Pierlorenzo; Cianflone, Alessandra; Nagy, Rebecca; Alder, Hansjuerg; Calin, George A.; Trapasso, Francesco; Giordano, Carla; Croce, Carlo M.; de la Chapelle, Albert; Fusco, Alfredo/titolo:Role of PTPRJ genotype in papillary thyroid carcinoma risk/doi:10.1677%2FERC-10-0143/rivista:Endocrine-related cancer/anno:2010/pagina_da:1001/pagina_a:1006/intervallo_pagine:1001–1006/volume:17
The strong genetic predisposition to papillary thyroid carcinoma (PTC) might be due to a combination of low-penetrance susceptibility variants. Thus, the research into gene variants involved in the increase of susceptibility to PTC is a relevant fiel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a088e9d0a502179af08666c66a6a2efa